- PTQQF shares dipped for a short time after a delayed, but ultimately clean, audit opinion created confusion and concern.
- Shares quickly ripped as more confident investors pounced on momentary selling, realized the company remains fundamentally solid and primed for continued revenue growth and margin expansion.
- PTQQF will almost certainly be listed on the NASDAQ exchange in early 2Q 2021, making them a candidate for inclusion in the Russell 2000 index.
- The PTQQF story being shared more deliberately with US investors is creating a nice tailwind for the share price.
- On a forward EBITDA multiple valuation, PTQQF shares remain undervalued, with a possible 250% upside over 3-5 years.
For further details see:
Protech Home Medical: Valuation Below Peers With Multiple Catalysts And Significant Upside